Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ying-Jun Chang

Showing results (141-150 of 236) with videos related to

Pageof 24
Sort By:
Nature Communications|December 31, 2024
Bone Marrow Endothelial Progenitor Cells remodelling facilitates normal hematopoiesis during Acute Myeloid Leukemia Complete RemissionTong Xing, Li-Juan Hu, Hong-Yan Zhao, et al.
Clinical Transplantation|July 5, 2024
Cytology or Multiparameter Flow Cytometry Positivity in the Cerebrospinal Fluid Before Transplantation is Predictive of Poor Outcomes After Allotransplantation in Acute Myeloid Leukemia PatientsLi-Juan Hu, Guo-Mei Fu, Yuan-Yuan Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2016
Controlled, Randomized, Open-Label Trial of Risk-Stratified Corticosteroid Prevention of Acute Graft-Versus-Host Disease After Haploidentical TransplantationYing-Jun Chang, Lan-Ping Xu, Yu Wang, et al.
Annals of Hematology|August 4, 2016
Clinical characteristics and risk factors of Intracranial hemorrhage in patients following allogeneic hematopoietic stem cell transplantationXiao-Hui Zhang, Qian-Ming Wang, Huan Chen, et al.
Leukemia & Lymphoma|July 1, 2021
Interferon-α as maintenance therapy can significantly reduce relapse in patients with favorable-risk acute myeloid leukemiaHao Jiang, Xiao-Hong Liu, Jun Kong, et al.
Bone Marrow Transplantation|April 13, 2021
Risk factors and outcomes of diffuse alveolar haemorrhage after allogeneic haematopoietic stem cell transplantationJin Wu, Hai-Xia Fu, Yun He, et al.
Signal Transduction and Targeted Therapy|May 4, 2025
Overexpressing natural killer group 2 member A drives natural killer cell exhaustion in relapsed acute myeloid leukemiaJuan Xie, Xue-Fei Liu, Tong Zhou, et al.
British Journal of Haematology|April 27, 2024
A complete oral regimen for induction therapy of patients with high-risk APL: An oral etoposide instead of intravenous infusion for cytoreductive chemotherapyFei-Fei Tang, Wen-Bing Duan, Xiao-Hong Liu, et al.
British Journal of Haematology|November 15, 2018
Hepatitis E virus infection after haploidentical haematopoietic stem cell transplantation: incidence and clinical courseFei-Fei Tang, Xiao-Dong Mo, Yu Wang, et al.
Oncoimmunology|February 10, 2017
Lower incidence of acute GVHD is associated with the rapid recovery of CD4<sup>+</sup>CD25<sup>+</sup>CD45RA<sup>+</sup> regulatory T cells in patients who received haploidentical allografts from NIMA-mismatched donors: A retrospective (development) and prospective (validation) cohort-based studyYu Wang, Xiang-Yu Zhao, Lan-Ping Xu, et al.
Pageof 24

Showing results (141-150 of 236) with videos related to

Sort By:
Pageof 24
Nature Communications|December 31, 2024
Bone Marrow Endothelial Progenitor Cells remodelling facilitates normal hematopoiesis during Acute Myeloid Leukemia Complete RemissionTong Xing, Li-Juan Hu, Hong-Yan Zhao, et al.
Clinical Transplantation|July 5, 2024
Cytology or Multiparameter Flow Cytometry Positivity in the Cerebrospinal Fluid Before Transplantation is Predictive of Poor Outcomes After Allotransplantation in Acute Myeloid Leukemia PatientsLi-Juan Hu, Guo-Mei Fu, Yuan-Yuan Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2016
Controlled, Randomized, Open-Label Trial of Risk-Stratified Corticosteroid Prevention of Acute Graft-Versus-Host Disease After Haploidentical TransplantationYing-Jun Chang, Lan-Ping Xu, Yu Wang, et al.
Annals of Hematology|August 4, 2016
Clinical characteristics and risk factors of Intracranial hemorrhage in patients following allogeneic hematopoietic stem cell transplantationXiao-Hui Zhang, Qian-Ming Wang, Huan Chen, et al.
Leukemia & Lymphoma|July 1, 2021
Interferon-α as maintenance therapy can significantly reduce relapse in patients with favorable-risk acute myeloid leukemiaHao Jiang, Xiao-Hong Liu, Jun Kong, et al.
Bone Marrow Transplantation|April 13, 2021
Risk factors and outcomes of diffuse alveolar haemorrhage after allogeneic haematopoietic stem cell transplantationJin Wu, Hai-Xia Fu, Yun He, et al.
Signal Transduction and Targeted Therapy|May 4, 2025
Overexpressing natural killer group 2 member A drives natural killer cell exhaustion in relapsed acute myeloid leukemiaJuan Xie, Xue-Fei Liu, Tong Zhou, et al.
British Journal of Haematology|April 27, 2024
A complete oral regimen for induction therapy of patients with high-risk APL: An oral etoposide instead of intravenous infusion for cytoreductive chemotherapyFei-Fei Tang, Wen-Bing Duan, Xiao-Hong Liu, et al.
British Journal of Haematology|November 15, 2018
Hepatitis E virus infection after haploidentical haematopoietic stem cell transplantation: incidence and clinical courseFei-Fei Tang, Xiao-Dong Mo, Yu Wang, et al.
Oncoimmunology|February 10, 2017
Lower incidence of acute GVHD is associated with the rapid recovery of CD4<sup>+</sup>CD25<sup>+</sup>CD45RA<sup>+</sup> regulatory T cells in patients who received haploidentical allografts from NIMA-mismatched donors: A retrospective (development) and prospective (validation) cohort-based studyYu Wang, Xiang-Yu Zhao, Lan-Ping Xu, et al.
Pageof 24